Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 15,000 shares at $42.38 ($638K) on 2014-11-03, disclosed to the SEC on 2014-11-04.
Scheduled sale ($638k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.38 | 11,777 | $499K | 78.2% |
| 2 | $43.05 | 3,223 | $139K | 21.8% |
| Total | $42.52 avg | 15,000 | $638K | 100% |
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |